查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2158734

側向流動免疫檢測膜市場：全球市場預測，2026-2032年

Lateral Flow Immunoassay Membrane Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，側向流動免疫檢測膜市場將成長至 31.1 億美元，複合年成長率為 9.19%。

主要市場統計數據
基準年 2025 16.8億美元
預計年份：2026年 18.3億美元
預測年份 2032 31.1億美元
複合年成長率 (%) 9.19%

側向流動免疫檢測膜：概述

側向流動免疫檢測膜是快速診斷系統中至關重要的功能組件，能夠實現可控的檢體傳輸、試劑相互作用以及肉眼可見的檢測線的形成。其性能取決於多種特性，例如孔結構、毛細流動、蛋白質結合行為、厚度、表面均勻性以及與檢測化學試劑的兼容性。分散式檢查、傳染病篩檢、懷孕和不孕症檢測、獸醫診斷、食品安全應用以及新興的床邊檢測等領域的廣泛應用推動了市場對側向流動免疫分析膜的需求。採購者越來越重視膜的性能，不再將其視為獨立的耗材，而是將其視為整合診斷平台的一部分，更加重視其可重複性、法規文件、供應穩定性以及與自動化生產的兼容性。

從通用底物到提高檢測性能的元素

產業趨勢正從簡單的基礎材料選擇轉向針對特定應用的膜工程設計。診斷設備開發商要求更精確地控制毛細管流量、降低批間差異、提高訊號清晰度並能夠處理更小的檢體。這些需求推動了膜製造、試劑配方、試紙組裝、讀數器設計和品質保證等各環節的跨學科合作。

人工智慧加速了設計、品管和需求。

人工智慧主要透過檢測方法開發、生產控制和診斷結果解讀來影響市場。借助機器學習工具，研究人員可以將膜的特性（例如孔隙分佈、潤濕性和結合性能）與檢測結果關聯起來，從而減少對冗長試驗的依賴。在生產製造方面，電腦視覺和預測分析可以輔助進行試紙條對齊、試劑塗覆、生產線均勻性以及缺陷目視檢查。

區域洞察：診斷重點的差異影響膜需求

在北美，受監管的即時檢測、分散式醫療服務、獸醫應用以及快速響應能力是推動對高特性薄膜和全面文件需求的關鍵因素。在拉丁美洲，准入限制、公共衛生篩檢、本地化生產和研發以及對價格合理且能在波動的分銷條件下保持可靠性的檢測方法的需求，都在影響著市場。

集團洞察：貿易和監管網路影響部署

東協市場受跨境製造、醫療保健服務覆蓋範圍擴大以及監管框架多元化的影響，這為膜材標準化和區域供應鏈協調創造了機會。在金磚國家，顯著的公共衛生需求和對本土製造的強烈願望，正推動著技術轉移、在地化和永續採購的日益重視。

國家概況：不同製造和應用領域的優先事項

澳洲擁有完善的公共衛生基礎設施，並且對遠端和分散式檢測有著濃厚的興趣，因此檢測產品的保存期限和現場易用性至關重要。巴西龐大且多元化的醫療保健系統支援感染疾病、基層醫療和獸醫檢測等領域的應用，但本地生產和採購效率仍然是重要的挑戰。加拿大優先考慮品質、偏遠地區的可及性和可靠的配送。中國擁有強大的診斷試劑生產能力，並大力推動國內供應鏈、自動化和高通量檢測的發展。

領導階層優先事項：同時提升績效、韌性與合規性。

產業領導者應從預期的檢測流程出發，反向推導膜材要求，將孔隙結構、流速、黏合性能和表面處理與可衡量的臨床或營運結果連結起來。供應商合格不應僅依賴單價，還應包括批次間一致性、變更管理規範、可追溯性、產能透明度和緊急時應對計畫。

調查方法：基於證據的膜市場動態評估

本執行摘要對側向流動免疫檢測膜的應用及其推廣應用的影響因素進行了系統性的定性評估。分析內容包括薄膜的功能、檢測方法開發要求、分散式檢查趨勢、生產流程、監管要求、醫療服務模式、區域背景以及國家層面的產業能力。

結論：膜工程將在快速檢測的可靠性方面繼續發揮核心作用。

側向流動免疫檢測膜仍然是快速診斷設備可靠性、易用性和擴充性的基礎。與競爭對手的差異化優勢正轉向材料性能控制、針對特定檢測方法的工程設計、數位化品管系統、完善的採購體係以及基於證據的監管支持。儘管不同地區和國家的優先事項有所不同，但通用的發展方向是需要更快、更易用、更穩定且分散式檢查的檢測方法。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 側向流動免疫檢測膜市場：依感染疾病

  • COVID-19
  • HIV
  • 流感
  • 瘧疾

第8章 側向流動免疫檢測膜市場：依組件分類

  • 吸收墊/吸水墊/排泄墊
  • 背卡
  • 共軛墊
  • 膜/反應基質
  • 樣品墊

第9章 側向流動免疫檢測膜市場：依分析方法分類

  • 競爭性檢測形式
  • 多重檢測分析
  • 夾心法檢測形式

第10章：側向流動免疫檢測膜市場：依最終用戶分類

  • 動物用藥品
  • 診斷檢查室
  • 環境
  • 居家照護
  • 醫院和診所

第11章 側向流動免疫檢測膜市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 側向流動免疫檢測膜市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：側向流動免疫檢測膜市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • 3M Company
  • Advanced Microdevices Pvt. Ltd.
  • Ahlstrom Oyj
  • Axiva Sichem Private Limited
  • Cobetter Filtration Equipment Co., Ltd.
  • Cytiva US LLC
  • Danaher Corporation
  • Fortis Life Sciences, LLC
  • FUJIFILM Wako Pure Chemical Corporation
  • Hangzhou Anow Microfiltration Co., Ltd.
  • HiMedia Laboratories Private Limited
  • Lydall Performance Materials, Inc.
  • Merck KGaA
  • Minipore LLC
  • Nupore Filtration Systems Pvt. Ltd.
  • Pall Corporation
  • Porvair plc
  • Sartorius AG
  • Spring Biochem Pvt. Ltd.
  • Toray Industries, Inc.

第16章 主要專家

Product Code: MRR-4654A89DBBB9

The Lateral Flow Immunoassay Membrane Market is projected to grow by USD 3.11 billion at a CAGR of 9.19% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.68 billion
Estimated Year [2026] USD 1.83 billion
Forecast Year [2032] USD 3.11 billion
CAGR (%) 9.19%

Lateral Flow Immunoassay Membranes: Executive Overview

Lateral flow immunoassay membranes are critical functional components in rapid diagnostic devices, enabling controlled sample transport, reagent interaction, and visible test-line formation. Their performance depends on properties such as pore structure, capillary flow, protein-binding behavior, thickness, surface uniformity, and compatibility with assay chemistry. Demand is shaped by the wider adoption of decentralized testing, infectious-disease screening, pregnancy and fertility testing, veterinary diagnostics, food safety applications, and emerging near-patient assays. Buyers increasingly assess membranes as part of an integrated diagnostic platform rather than as an isolated consumable, placing greater emphasis on reproducibility, regulatory documentation, supply continuity, and compatibility with automated manufacturing.

From Commodity Substrate to Assay-Performance Enabler

The landscape is shifting from basic material selection toward application-specific membrane engineering. Diagnostic developers are seeking tighter control of capillary flow, reduced lot-to-lot variation, improved signal clarity, and compatibility with smaller sample volumes. These requirements are encouraging collaboration across membrane production, reagent formulation, strip assembly, reader design, and quality assurance.

Decentralized testing is also changing product priorities. Users increasingly expect rapid results, simple operation, stable storage, and consistent performance outside centralized laboratories. This favors membranes that can support compact formats, minimally trained operators, multiplexing, and broader environmental tolerances. At the same time, regulatory scrutiny and quality-system expectations are increasing the importance of traceability, validated processes, and documented material specifications.

Artificial Intelligence Accelerates Design, Quality Control, and Demand

Artificial intelligence is influencing the market primarily through assay development, manufacturing control, and diagnostic interpretation. Machine-learning tools can help researchers relate membrane characteristics-such as pore distribution, wetting behavior, and binding performance-to assay outcomes, reducing dependence on lengthy trial-and-error cycles. In production, computer vision and predictive analytics can support inspection of strip alignment, reagent deposition, line uniformity, and visible defects.

AI-enabled readers may also improve interpretation of faint or complex test results, particularly in multiplex or quantitative formats. However, the value of these tools depends on representative training data, validated algorithms, cybersecurity, explainability, and compliance with applicable medical-device requirements. AI is therefore best viewed as a cumulative capability that strengthens membrane and assay development when paired with robust laboratory validation, rather than as a substitute for physical performance testing.

Regional Insights: Different Diagnostic Priorities Shape Membrane Requirements

North America emphasizes regulated point-of-care testing, decentralized healthcare delivery, veterinary use, and rapid response preparedness, supporting demand for highly characterized membranes and strong documentation. Latin America is influenced by access constraints, public-health screening, local manufacturing development, and the need for affordable tests that remain reliable under variable distribution conditions.

Europe places substantial weight on quality systems, sustainability, performance consistency, and regulatory conformity across integrated diagnostic supply chains. The Middle East is developing diagnostic capacity through healthcare modernization, centralized procurement, and expanded screening programs, while environmental stability and logistics remain important considerations. Africa presents diverse requirements linked to infectious-disease surveillance, rural access, donor-supported programs, and test robustness in challenging operating environments. Asia-Pacific combines advanced research and manufacturing ecosystems with large-scale public-health needs, supporting innovation in compact, high-throughput, multiplex, and digitally interpreted lateral-flow formats.

Group Insights: Trade and Regulatory Networks Influence Adoption

ASEAN markets are shaped by cross-border manufacturing, expanding healthcare access, and varied regulatory systems, creating opportunities for standardized membrane specifications and regional supply-chain coordination. BRICS economies combine substantial public-health needs with domestic manufacturing ambitions, increasing attention to technology transfer, localization, and resilient sourcing.

The European Union benefits from harmonized regulatory structures and integrated industrial networks, although sustainability, documentation, and conformity requirements remain central. G7 markets generally prioritize advanced diagnostics, reproducibility, traceability, and high-performance materials. GCC countries are strengthening laboratory and point-of-care capacity through healthcare investment and centralized purchasing, with product localization and climate resilience becoming more relevant. NATO members' preparedness priorities support interest in rapidly deployable diagnostics, secure supply chains, and materials suitable for emergency and field settings.

Country Insights: Diverse Manufacturing and Application Priorities

Australia combines strong public-health infrastructure with interest in remote and decentralized testing, making storage stability and field usability important. Brazil's large and diverse healthcare system supports applications in infectious disease, primary care, and veterinary testing, while local production and procurement efficiency remain relevant. Canada emphasizes quality, accessibility across remote communities, and dependable distribution. China has extensive diagnostic manufacturing capacity and is advancing domestic supply chains, automation, and high-throughput testing.

France, Germany, Italy, and Spain operate within European quality and regulatory frameworks while supporting hospital, laboratory, public-health, and decentralized applications. India combines major diagnostic access needs with growing domestic manufacturing, affordability pressures, and interest in scalable production. Japan emphasizes precision, reliability, miniaturization, and mature quality controls. Mexico is influenced by cross-border manufacturing, public-health screening, and cost-sensitive procurement. Russia's market environment is shaped by domestic supply considerations and healthcare-system resilience.

South Korea is recognized for advanced diagnostics, automation, and digital integration. The United Kingdom places emphasis on validated performance, decentralized care, and robust procurement standards. The United States remains a major center for diagnostic innovation, regulatory development, emergency preparedness, and near-patient testing, increasing demand for well-characterized membranes that support consistent assay performance.

Priorities for Leaders: Build Performance, Resilience, and Compliance Together

Industry leaders should define membrane requirements from the intended assay workflow backward, linking pore structure, flow rate, binding behavior, and surface treatment to measurable clinical or operational outcomes. Supplier qualification should include lot consistency, change-control discipline, traceability, capacity visibility, and contingency planning rather than relying solely on unit cost.

Investment in pilot-scale testing, automated inspection, digital process monitoring, and statistically designed experiments can improve reproducibility and shorten development cycles. Leaders should also prepare for growing expectations around sustainability by evaluating material efficiency, packaging, waste reduction, and end-of-life considerations without compromising analytical performance. Finally, organizations should establish cross-functional governance covering regulatory evidence, AI validation, cybersecurity, quality management, and regional commercialization requirements.

Methodology: Evidence-Led Assessment of Membrane Market Dynamics

This executive summary uses a structured qualitative assessment of lateral flow immunoassay membrane applications and the factors influencing adoption. The analysis considers membrane functionality, assay-development requirements, decentralized-testing trends, manufacturing practices, regulatory expectations, healthcare delivery models, regional conditions, and country-level industrial capabilities.

Insights are synthesized across the specified regions, economic and institutional groups, and countries. The approach distinguishes established applications from emerging use cases and separates material-level considerations from broader diagnostic-platform trends. No market estimates, market shares, forecasts, or company-specific claims are used; conclusions are limited to defensible themes supported by known industry, technology, healthcare, and regulatory dynamics.

Conclusion: Membrane Engineering Will Remain Central to Rapid-Test Reliability

Lateral flow immunoassay membranes remain foundational to the reliability, usability, and scalability of rapid diagnostic devices. Competitive differentiation is moving toward controlled material performance, assay-specific engineering, digital quality systems, resilient sourcing, and evidence-based regulatory support. Regional and country priorities vary, but the common direction is toward tests that are faster, easier to use, more consistent, and suitable for decentralized settings.

Organizations that treat membrane selection as a strategic part of assay architecture will be better positioned to improve performance and manage development risk. The strongest long-term approach combines material science, manufacturing discipline, application-specific validation, responsible AI adoption, and supply-chain resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Lateral Flow Immunoassay Membrane Market, by Infectious Diseases

  • 7.1. Introduction
  • 7.2. Covid-19
  • 7.3. HIV
  • 7.4. Influenza
  • 7.5. Malaria

8. Lateral Flow Immunoassay Membrane Market, by Component

  • 8.1. Introduction
  • 8.2. Absorbent Pad / Wick / Waste Pad
  • 8.3. Backing Card
  • 8.4. Conjugate Pad
  • 8.5. Membrane / Reaction Matrix
  • 8.6. Sample Pad

9. Lateral Flow Immunoassay Membrane Market, by Assay Technique

  • 9.1. Introduction
  • 9.2. Competitive assay format
  • 9.3. Multiplex detection assays
  • 9.4. Sandwich assay format

10. Lateral Flow Immunoassay Membrane Market, by End-User

  • 10.1. Introduction
  • 10.2. Animal Health
  • 10.3. Diagnostic Laboratories
  • 10.4. Environmental
  • 10.5. Home-care
  • 10.6. Hospitals and Clinics

11. Lateral Flow Immunoassay Membrane Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Lateral Flow Immunoassay Membrane Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Lateral Flow Immunoassay Membrane Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. 3M Company
  • 15.2. Advanced Microdevices Pvt. Ltd.
  • 15.3. Ahlstrom Oyj
  • 15.4. Axiva Sichem Private Limited
  • 15.5. Cobetter Filtration Equipment Co., Ltd.
  • 15.6. Cytiva US LLC
  • 15.7. Danaher Corporation
  • 15.8. Fortis Life Sciences, LLC
  • 15.9. FUJIFILM Wako Pure Chemical Corporation
  • 15.10. Hangzhou Anow Microfiltration Co., Ltd.
  • 15.11. HiMedia Laboratories Private Limited
  • 15.12. Lydall Performance Materials, Inc.
  • 15.13. Merck KGaA
  • 15.14. Minipore LLC
  • 15.15. Nupore Filtration Systems Pvt. Ltd.
  • 15.16. Pall Corporation
  • 15.17. Porvair plc
  • 15.18. Sartorius AG
  • 15.19. Spring Biochem Pvt. Ltd.
  • 15.20. Toray Industries, Inc.

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Lateral Flow Immunoassay Membrane Market, Years Considered for the Study
  • FIGURE 2. Global Lateral Flow Immunoassay Membrane Market, Research Design
  • FIGURE 3. Global Lateral Flow Immunoassay Membrane Market, Research Framework
  • FIGURE 4. Global Lateral Flow Immunoassay Membrane Market, Data Triangulation
  • FIGURE 5. Global Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2025 vs 2032 (%)
  • FIGURE 7. Global Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Lateral Flow Immunoassay Membrane Market Size, by Component, 2025 vs 2032 (%)
  • FIGURE 9. Global Lateral Flow Immunoassay Membrane Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2025 vs 2032 (%)
  • FIGURE 11. Global Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Lateral Flow Immunoassay Membrane Market Size, by End-User, 2025 vs 2032 (%)
  • FIGURE 13. Global Lateral Flow Immunoassay Membrane Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Lateral Flow Immunoassay Membrane Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Lateral Flow Immunoassay Membrane Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Lateral Flow Immunoassay Membrane Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Lateral Flow Immunoassay Membrane Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Lateral Flow Immunoassay Membrane Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Lateral Flow Immunoassay Membrane Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Lateral Flow Immunoassay Membrane Market Segmentation & Coverage
  • TABLE 2. Global Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 4. Global Covid-19 Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Covid-19 Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Covid-19 Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global HIV Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global HIV Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global HIV Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Influenza Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Influenza Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Influenza Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Malaria Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Malaria Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Malaria Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 17. Global Absorbent Pad / Wick / Waste Pad Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Absorbent Pad / Wick / Waste Pad Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Absorbent Pad / Wick / Waste Pad Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Backing Card Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Backing Card Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Backing Card Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Conjugate Pad Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Conjugate Pad Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Conjugate Pad Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Membrane / Reaction Matrix Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Membrane / Reaction Matrix Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Membrane / Reaction Matrix Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Sample Pad Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Sample Pad Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Sample Pad Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 33. Global Competitive assay format Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Competitive assay format Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Competitive assay format Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Multiplex detection assays Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Multiplex detection assays Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Multiplex detection assays Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Sandwich assay format Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Sandwich assay format Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Sandwich assay format Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 43. Global Animal Health Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Animal Health Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Animal Health Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Environmental Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Environmental Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Environmental Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Home-care Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Home-care Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Home-care Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Hospitals and Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Hospitals and Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Hospitals and Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Lateral Flow Immunoassay Membrane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Asia-Pacific Lateral Flow Immunoassay Membrane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Asia-Pacific Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 61. Asia-Pacific Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 62. Asia-Pacific Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 64. North America Lateral Flow Immunoassay Membrane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. North America Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 66. North America Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 67. North America Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 68. North America Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 69. Latin America Lateral Flow Immunoassay Membrane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Latin America Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 71. Latin America Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 72. Latin America Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 73. Latin America Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 74. Europe Lateral Flow Immunoassay Membrane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Europe Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 76. Europe Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 77. Europe Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 78. Europe Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 79. Middle East Lateral Flow Immunoassay Membrane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. Middle East Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 81. Middle East Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 82. Middle East Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 83. Middle East Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 84. Africa Lateral Flow Immunoassay Membrane Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Africa Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 86. Africa Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 87. Africa Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 88. Africa Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 89. Global Lateral Flow Immunoassay Membrane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 90. ASEAN Lateral Flow Immunoassay Membrane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. ASEAN Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 92. ASEAN Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 93. ASEAN Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 94. ASEAN Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 95. GCC Lateral Flow Immunoassay Membrane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 96. GCC Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 97. GCC Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 98. GCC Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 99. GCC Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 100. European Union Lateral Flow Immunoassay Membrane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 101. European Union Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 102. European Union Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 103. European Union Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 104. European Union Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 105. BRICS Lateral Flow Immunoassay Membrane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. BRICS Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 107. BRICS Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 108. BRICS Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 109. BRICS Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 110. G7 Lateral Flow Immunoassay Membrane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 111. G7 Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 112. G7 Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 113. G7 Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 114. G7 Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 115. NATO Lateral Flow Immunoassay Membrane Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 116. NATO Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 117. NATO Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 118. NATO Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 119. NATO Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 120. Global Lateral Flow Immunoassay Membrane Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 121. United States Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 122. United States Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 123. United States Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 124. United States Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 125. United States Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 126. Canada Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 127. Canada Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 128. Canada Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 129. Canada Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 130. Canada Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 131. Mexico Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 132. Mexico Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 133. Mexico Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 134. Mexico Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 135. Mexico Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 136. Brazil Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 137. Brazil Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 138. Brazil Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 139. Brazil Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 140. Brazil Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 141. United Kingdom Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 142. United Kingdom Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 143. United Kingdom Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 144. United Kingdom Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 145. United Kingdom Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 146. Germany Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 147. Germany Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 148. Germany Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 149. Germany Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 150. Germany Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 151. France Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 152. France Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 153. France Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 154. France Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 155. France Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 156. Russia Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 157. Russia Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 158. Russia Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 159. Russia Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 160. Russia Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 161. Italy Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 162. Italy Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 163. Italy Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 164. Italy Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 165. Italy Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 166. Spain Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 167. Spain Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 168. Spain Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 169. Spain Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 170. Spain Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 171. China Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 172. China Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 173. China Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 174. China Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 175. China Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 176. India Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 177. India Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 178. India Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 179. India Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 180. India Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 181. Japan Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 182. Japan Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 183. Japan Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 184. Japan Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 185. Japan Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 186. Australia Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 187. Australia Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 188. Australia Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 189. Australia Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 190. Australia Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 191. South Korea Lateral Flow Immunoassay Membrane Market Size, 2017-2032 (USD Million)
  • TABLE 192. South Korea Lateral Flow Immunoassay Membrane Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 193. South Korea Lateral Flow Immunoassay Membrane Market Size, by Component, 2017-2032 (USD Million)
  • TABLE 194. South Korea Lateral Flow Immunoassay Membrane Market Size, by Assay Technique, 2017-2032 (USD Million)
  • TABLE 195. South Korea Lateral Flow Immunoassay Membrane Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 196. Global Lateral Flow Immunoassay Membrane Market Share, by Key Player, 2025
  • TABLE 197. Global Lateral Flow Immunoassay Membrane Market, Key Experts